Mumbai: Jubilant Pharmova Limited reported a sharp decline in profitability during the second quarter of FY27, with its net profit falling approximately 74% year-on-year to ₹31 crore, despite strong revenue growth in its generics and sterile injectables businesses. The pharmaceutical company reported total income of ₹2,384 crore for the quarter ended September 30, 2026.